ENGLISH
|
JAPANESE
|
CONNECT WITH US:
Home
About
Contact
Log in
*
Home
Press release
Sep 29, 2022 19:40 JST
Source:
Black Spade Capital Limited
My Platform Joint Venture Awarded the Winner's Prize in the 2022 Hong Kong-Macau-Taiwan Innovation and Entrepreneurship Competition
HONG KONG, Sep 29, 2022 - (ACN Newswire) - My Platform, the MedTech venture in which Black Spade Capital Limited ("Black Spade Capital") invested, has just announced that its PRC joint venture My Platform Information Technology (Guangzhou) Limited ("My Platform MedTech") was in the 2022 Hong Kong-Macau-Taiwan Innovation and Entrepreneurship Competition organised by the Guangzhou awarded the Winner's Prize Municipal Science and Technology Bureau.
(1st from the Right) Mr. Jesse Ho, Chief Executive Officer of My Platform
The competition brings together 226 participants from a wide variety of industries to honour the key players from Hong Kong, Macau and Taiwan for their achievement in the innovative and technology areas. My Platform MedTech ranked top 16 among the companies who received the award.
My Platform MedTech is a joint venture established by My Platform and its partner in Guangzhou in 2021. It provides cloud-based services and doctor-patient community chatroom with telemedicine functions to hospitals and helps build an enclosed communication system between doctors and patients, which strengthens the connection between different specialist departments with patients and increases patient stickiness.
In view of the growing demand for distant medical consultation, My Platform upgraded its system with telemedicine capabilities in 2020. This built-in function enables integration with other features thus offering a seamless and user-friendly experience.
Mr. Jesse Ho, CEO of My Platform, said: "we are incredibly honoured to receive this award. It's a reflection of our team effort and the impact that we and our partners are making in the implementation of various initiatives to drive the technology development in the medical industry in the Greater Bay Area. We will continue with our good work to improve greater efficiency and better communication in the healthcare industry."
About Black Spade Capital Limited
Black Spade Capital Limited is an established family office managing the private investments of Mr. Lawrence Ho. Headquartered in Hong Kong, its global portfolio consists of a wide spectrum of cross-border investments as it consistently seeks to add new projects and opportunities to its investment mix. Black Spade Capital's investment strategy maximises coverage of geographic regions and sectors whilst maintaining a portfolio of diversified asset classes, ranging from equity, fixed income, pre-IPO investments, medical technology, leisure and culture, green energy, real estate to Web3. In July 2021, Black Spade Acquisition Co (NYSE: BSAQ), a special purpose acquisition company of which a subsidiary of Black Spade Capital is sponsor, was listed on the New York Stock Exchange.
About My Platform Information Technology (Guangzhou) Limited
My Platform is a global multi-party interactive cloud-based SaaS platform that provides a seamless experience in the healthcare industry for professionals and end-users. With over 20 years of experience in the medical, finance and IT fields, My Platform is dedicated to reshape the medical ecosystem and eliminate misinformation. Its powerful proprietary software can connect doctors, patients (members), pharmaceutical companies, insurance companies, hospitals and corporations and allows them to interact on one single platform. The all-integrated clinic solution built with state-of-the-art technology facilitates daily operation for all.
Source: Black Spade Capital Limited
Sectors: Healthcare & Pharm, PE, VC & Alternatives
Copyright ©2025 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.
Latest Release
International Consortium Rolls Out Major EV Battery Swapping Initiative in Tokyo
Jun 06, 2025 16:42 JST
TANAKA PRECIOUS METAL TECHNOLOGIES Receives 2025 Technology Award from Catalyst Manufacturers Association, Japan, for Development and Practical Application of Electrode Catalysts for PEM Water Electrolysis
Jun 06, 2025 11:00 JST
Fujitsu unveils Technology and Service Vision 2025: People-AI collaboration for a net positive future
Jun 06, 2025 10:44 JST
Alpha Growth plc: Alpha Alternative Assets Fund Update ("AAAF")
Jun 04, 2025 15:00 JST
MHI Thermal Systems Receives A' Design Awards
Jun 04, 2025 14:10 JST
Orange completes successful trial of Fujitsu 1FINITY optical transport solution
Jun 04, 2025 12:58 JST
Implementation of Measures to Enhance Our Corporate Value in Connection with Toyota Industries Corporation
Jun 03, 2025 19:54 JST
Toyota Group to Accelerate Collaboration Towards Transforming into a Mobility Company Through Privatization of Toyota Industries Corporation
Jun 03, 2025 19:16 JST
Fujitsu accelerates digital transformation of financial institutions with newly systematized business strategy
Jun 03, 2025 18:46 JST
Anime Tokyo Station Launches Official YouTube Channel
Jun 03, 2025 11:00 JST
Transgene and NEC Present Durable Disease-Free Survival and Sustained T Cell Responses at 24 months with Individualized Cancer Vaccine TG4050
Jun 02, 2025 17:56 JST
Eisai to Launch "Pariet S," the First Proton Pump Inhibitor RX-to-OTC in Japan
Jun 02, 2025 17:46 JST
Mitsubishi Corporation to Invest and Enter into a Business Partnership with DEScycle Ltd., a UK Company Developing Innovative Metal Recycling Technology
Jun 02, 2025 14:35 JST
MyJCB App Wins Gold at A' Design Award & Competition
Jun 02, 2025 12:00 JST
Fujitsu Technology Park's redevelopment project launch
Jun 02, 2025 11:23 JST
Mitsubishi Corporation Establishes New Corporate Venture Capital Company
May 30, 2025 18:36 JST
Honda to Co-develop Refueling Port Connecting System for On-orbit Satellite Refueling with Astroscale
May 30, 2025 11:54 JST
IFS and NEC Strengthen their Strategic Partnership to Create New Value
May 30, 2025 10:11 JST
Mazda Production and Sales Results for April 2025
May 29, 2025 18:44 JST
New Drug Approval for In-House Developed Anti-Insomnia Drug DAYVIGO (Lemborexant) in China
May 28, 2025 17:45 JST
More Latest Release >>
Related Release
The Generation Essentials Group and Black Spade Acquisition II Co Complete Business Combination
June 05 2025 11:33 JST
S Experience and Kingsmen Xperience Announce a Strategic Partnership Deal Memorandum
February 13 2025 18:47 JST
Black Spade joins UBS Finance Summit 2024 in Qatar
November 11 2024 10:43 JST
Black Spade Acquisition II Co Announces Pricing Of $150 Million Initial Public Offering
August 28 2024 11:19 JST
Black Spade Capital and UBS Co-hosted Successful Business Reception in Hanoi
June 03 2024 18:11 JST
Black Spade shares investment insights at Global Investment Panel of BEYOND Wealth Summit for Family Offices
May 23 2024 18:22 JST
Black Spade Donates Art and Jewellery Collection To Hong Kong Red Cross
April 25 2024 20:40 JST
VinFast To Publicly List Through Business Combination With Black Spade Acquisition Co
May 12 2023 21:32 JST
Black Spade Capital Fully Supports the Development of Family Office Businesses in Hong Kong
April 03 2023 18:12 JST
iRad inaugurates 3 new medical scanning diagnostic centres this year
June 14 2022 17:28 JST
More Press release >>